wavepaths
Wavepaths is a London-based, fully remote company that develops an AI-driven adaptive music platform for psychedelic therapy, ketamine treatment, breathwork, and psychotherapy, serving 5,000+ practitioners across 29 countries and supporting 50,000+ clinical sessions.
- Company typePrivate
- Founded2019
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What wavepaths does
Wavepaths is a London-headquartered, fully remote company that develops an AI-driven adaptive music generation platform designed to support therapist-led experiences across psychedelic therapy, ketamine infusion therapy, breathwork, and general psychotherapy. The platform generates personalised, real-time music by weaving together exclusive contributions from over 30 collaborating artists (including Jon Hopkins, Brian Eno, and Robert Rich), with in-session adaptation tuned to the individual, the therapeutic context, and the medicine being used. The company was founded in 2019 by Dr. Mendel Kaelen, a neuroscientist whose PhD research at Imperial College London first demonstrated music's central role in psychedelic therapy outcomes, and co-founder Anna Rickman.
The product surface comprises specialised offerings for each therapeutic modality — Music for Psychedelic Therapy, Music for Ketamine Infusion Therapy (covering both KAP and KIT), Music for Breathwork, and Music for Psychotherapy — plus a research tier supporting clinical trials at Imperial College London, McGill University, University of Washington, and Monash University. Supporting services include the Foundations of Therapeutic Music training course (€350 self-paced / €1,300 live), 1:1 and group consulting with Dr. Kaelen, and Deep Listening sessions facilitated over Zoom.
Wavepaths operates a primarily subscription-based revenue model (monthly practitioner access with 14-day free trials and category-specific discounts), complemented by fee-based training, consulting, and facilitated listening services. GTM is community-led and self-serve, amplified by free webinars, founder-led AMAs, and academic research partnerships. The platform is used by 5,000+ practitioners across 29 countries and has supported 50,000+ clinical sessions; the company raised $4.5M in seed funding in November 2021 from a consortium of psychedelic- and science-focused investors.
wavepaths firmographics
Firmographics- Name
- wavepaths
- Legal name
- Wavepaths
- Website
- https://wavepaths.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Wavepaths is a London-based, fully remote company that develops an AI-driven adaptive music platform for psychedelic therapy, ketamine treatment, breathwork, and psychotherapy, serving 5,000+ practitioners across 29 countries and supporting 50,000+ clinical sessions.
- Ownership category
- akta.pro rank
wavepaths industry classification
Industry- Product category
- Therapeutic Music Software
- NAICS
- Other Sound Recording Industries (512290), Sound Recording Industries (5122)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Mobile Music Creation Apps (Beatmaking, Songwriting, Practice) (MPAIAIAC)
- akta.pro secondary industry
- Sound Meditation & Sound Bath Sessions (HSADAJAD)
Keywords
Where wavepaths is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
wavepaths business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Subscription Platform Access: Monthly subscription model for care providers to access the Wavepaths music platform for therapeutic sessions. Includes free trial periods and discounts for certain practitioner categories.
- Music Licensing for Breathwork: $25 per month licensing fee during beta phase for breathwork practitioners to use adaptive music.
- Educational Training Programs: Fee-based training courses including the Foundations of Therapeutic Music program (€350 for self-paced, €1,300 for live interactive), and 1:1/group consulting sessions with founder Mendel Kaelen.
- Deep Listening Sessions: Paid deep listening sessions facilitated over Zoom, offered individually or for groups, lasting 1-3 hours.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Breathwork music licensing - beta pricing |
| Subscription | Pay-as-you-go | Foundations of Therapeutic Music - Essentials (Self-Paced) |
| Subscription | Pay-as-you-go | Foundations of Therapeutic Music - Expert (Live Interactive) |
| Freemium | Pay-as-you-go | Platform Free Trial |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
wavepaths product offering
Product offeringCore offering
Wavepaths provides an AI-driven, person-centred adaptive music platform used by therapists, ketamine clinics, breathwork facilitators, and researchers during therapeutic sessions. The platform weaves exclusive musical contributions from over 30 world-renowned artists together in real time, adapting to the individual patient, the therapeutic context, and the medicine involved. Supporting offerings include an educational Foundations of Therapeutic Music training course, 1:1/group consulting, and facilitated Deep Listening sessions.
Product overview
Wavepaths is a music-as-medicine platform offering adaptive, person-centred therapeutic music solutions. The core platform includes multiple specialized applications: Music for Psychedelic Therapy, Music for Ketamine Infusion Therapy, Music for Breathwork, and Music for Psychotherapy. Supporting offerings include Deep Listening sessions (guided introspective music experiences), research support for clinical trials, and subscription access for care providers. Wavepaths' technology weaves musical contributions from over 30 collaborating artists together in real-time, adapting to each individual and therapeutic context. The platform is complemented by educational programs including a Foundations of Therapeutic Music training course and 1:1 consulting services. The company serves practitioners across 29 countries and supports over 50,000 clinical sessions.
Differentiator
Problem solved
Functional benefit
Products and services
- Music for Psychedelic Therapy Adaptive, person-centred music platform designed to optimize therapeutic outcomes during psychedelic-assisted therapy sessions (psilocybin, MDMA, DMT) by customising music to the pharmacodynamics of the medicine and individual patient traits. Targeted at therapists, guides, and clinicians.
- Music for Ketamine Infusion Therapy Therapeutic music solution for ketamine-assisted psychotherapy (KAP) and ketamine IV therapy (KIT) practitioners, supporting both infusion-only practices and psychotherapy sessions. Targeted at ketamine clinics and practitioners.
- Music for Breathwork Adaptive music platform for breathwork practitioners, featuring real-time adaptability to session rhythm and remote session capabilities via sharable music links. Targeted at body-mind practitioners including breathwork facilitators and yoga teachers.
- Music for Psychotherapy Person-centred music solution designed to support psychotherapists and mental health practitioners in integrating music into their therapeutic practice. Targeted at general psychotherapists, psychiatrists, and counselors.
- For Researchers Access to the Wavepaths music platform and research support for clinical trials involving MDMA, psilocybin, DMT and other psychedelic medicines. Targeted at university and clinical research institutions.
- Deep Listening Paid transformative music listening method providing guided, introspective experiences that foster meaning-making and emotional insight, facilitated over Zoom by Dr. Mendel Kaelen. Sessions last 1-3 hours and combine live-guided music experiences with post-session integration. Targeted at individuals and groups seeking introspective experiences.
- Foundations of Therapeutic Music 14-week experiential training and mentorship program teaching therapeutic musicality, situational flexibility, and multidisciplinary integration. Available in self-paced Essentials (€350) and live interactive Expert (€1,300) formats. Includes live sessions, playlist design workshops, and a Wavepaths subscription. Targeted at practitioners seeking to integrate music into therapeutic practice.
- 1:1 & Group Consultation Individual and group consulting services with Dr. Mendel Kaelen drawing on 15+ years of therapeutic music research and application. Available for groups up to 6, up to 12, or 12+ people. Targeted at practitioners and organisations seeking personalised guidance on therapeutic music integration.
Quantifiable outcome
- All three positive therapeutic outcomes (mystical experience, autobiographical insight, depression reduction) were more likely when patients responded positively to music in psychedelic therapy studies
- +1 more outcomes
Companies that use wavepaths
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles5 records
wavepaths technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature3 records
wavepaths partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, major and minor.
- McGill UniversitycoreAcademic research partnership supporting clinical trials with psychedelic medicines. One of several research institution partnerships.
- University of WashingtoncoreAcademic research partnership supporting clinical trials. Wavepaths is supporting ongoing research into psychedelic therapy at this institution.
- Monash UniversitycoreAcademic research partnership supporting clinical trials. Wavepaths is supporting ongoing research into psychedelic therapy at this institution.
- Brian EnomajorCollaboration on popup research space in 2020. Eno participated in the validation of core hypotheses through a popup experiential space in Brick Lane, London.
- Jon HopkinsmajorEarly contributor and collaborator since 2019. Hopkins is one of the first contributors to Wavepaths, bringing visionary creative input on music and consciousness.
- Imperial College LondoncoreResearch partnership where founder Mendel Kaelen conducted neuroscientific and clinical research on psychedelic therapy. Wavepaths was founded upon research demonstrating music's central role in psychedelic therapy conducted at Imperial College.
- TheraPsilminorNon-profit organization shown in partnership logos on Wavepaths website, supporting psychedelic therapy practitioners.
- London Contemporary OrchestraminorMusic collaboration relationship; Galya Bisengalieva, leader of the London Contemporary Orchestra, collaborates with Wavepaths as an artist.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
wavepaths competitors and assessment
Company assessmentBroad incumbents
- Calm: Large-scale mental wellness platform with Sleep Stories, music and meditations. Overlaps in wellness/mindfulness audio but operates as a mass-market consumer app without clinical personalization or therapeutic research backing.
- Headspace: Major mental health and meditation platform offering audio content including music and soundscapes. Comparable in mental wellness audio, but a broader incumbent without specialist therapeutic-music research focus.
Direct peers
- Endel: AI-driven personalized soundscapes for focus, sleep and relaxation. Closely comparable technology (real-time adaptive generative audio) and overlapping wellness/mental health end use, though Endel targets consumers rather than clinical practitioners.
- Brain.fm: AI-composed functional music engineered to influence cognitive states (focus, sleep, meditation). Directly comparable adaptive-music technology and therapeutic/wellness positioning, with similar research-led differentiation strategy.
- Mubert: Generative AI music platform producing real-time, royalty-cleared audio streams for apps, creators and brands. Comparable core technology (real-time generative music) with overlapping content-licensing business model, though Wavepaths targets therapeutic rather than commercial use cases.
Emerging players
- Aiva: AI music composition platform creating emotional soundtrack-style music. Shares the AI music generation technology stack but focuses on content creation for media rather than live therapeutic adaptation.
- LUCID: Wellness audio app producing immersive soundscapes for sleep and relaxation. Comparable wellness/mindfulness audio product, though lacking Wavepaths' clinical validation and live adaptation.
- iAwake Technologies: Producer of brainwave entrainment and therapeutic audio tracks for meditation, sleep and consciousness exploration. Adjacent therapeutic audio niche with similar end-user intent but static rather than adaptive delivery.
Others
- TheraPsil: Canadian non-profit advancing legal access to psilocybin-assisted therapy. Listed as a Wavepaths partner; serves the same psychedelic therapy ecosystem from an advocacy rather than technology angle.
- Compass Pathways: Clinical-stage psychedelic therapy company running psilocybin trials for treatment-resistant depression. Not a music peer but a leading buyer/sponsor of therapeutic music infrastructure within psychedelic clinical research.
Market position
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
wavepaths social profiles
Digital presencewavepaths financial estimates
Financial estimateRevenue estimate
Valuation estimate
wavepaths leadership team
Management profileNumber of profiles
Profiles7 records
wavepaths funding detail
Funding detailFunding overview
Funding rounds1 record
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
wavepaths M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about wavepaths
What does wavepaths do?
Wavepaths provides an AI-driven, person-centred adaptive music platform used by therapists, ketamine clinics, breathwork facilitators, and researchers during therapeutic sessions. The platform weaves exclusive musical contributions from over 30 world-renowned artists together in real time, adapting to the individual patient, the therapeutic context, and the medicine involved. Supporting offerings include an educational Foundations of Therapeutic Music training course, 1:1/group consulting, and facilitated Deep Listening sessions.
Is wavepaths a public or private company?
wavepaths is a private company. It is classified as venture growth investor backed and is currently operating.
When was wavepaths founded?
wavepaths was founded in 2019. It employs 11 to 50 people.
Where is wavepaths based?
wavepaths is headquartered in London, United Kingdom, in the Europe region.
How does wavepaths make money?
Four revenue lines are on record. Subscription Platform Access are the primary driver. The others are music Licensing for Breathwork, educational Training Programs and deep Listening Sessions.
Who are wavepaths's main competitors?
Broad incumbents on record are Calm and Headspace. Direct peers are Endel, Brain.fm and Mubert. Emerging players are Aiva, LUCID and iAwake Technologies. Others are TheraPsil and Compass Pathways.
Does wavepaths have an API?
No public API is recorded for wavepaths.
What industry is wavepaths in?
wavepaths's product category is Therapeutic Music Software. Its primary akta.pro industry code is MPAIAIAC, Mobile Music Creation Apps (Beatmaking, Songwriting, Practice), with a secondary code of HSADAJAD, Sound Meditation & Sound Bath Sessions. Its NAICS code is 512290 and its SIC code is 7370.